Quote | Avacta Group PLC (OTCMKTS:AVCTF)
Last: | $0.66 |
---|---|
Change Percent: | 0.0% |
Open: | $0.66 |
Close: | $0.66 |
High: | $0.66 |
Low: | $0.66 |
Volume: | 1,005 |
Last Trade Date Time: | 03/18/2024 03:00:00 am |
News | Avacta Group PLC (OTCMKTS:AVCTF)
5 March 2024 Avacta Group plc (“Avacta” or “the Group” or “the Company”) Updated Results from Single-Agent Phase 1 Clinical Trial of Peptide Drug Conjugate, AVA6000 to be Presented in a Poster at the American Association of Cancer Resear...
19 December 2023 Avacta Group plc (“Avacta” or “the Group” or “the Company”) Appointment of Chief Business Officer Appointment signals commercial emphasis for Avacta to leverage clinical progress Avacta Group plc (AIM: AVCT...
Message Board Posts | Avacta Group PLC (OTCMKTS:AVCTF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Avacta Group PLC Company Name:
AVCTF Stock Symbol:
OTCMKTS Market:
5 March 2024 Avacta Group plc (“Avacta” or “the Group” or “the Company”) Updated Results from Single-Agent Phase 1 Clinical Trial of Peptide Drug Conjugate, AVA6000 to be Presented in a Poster at the American Association of Cancer Resear...
19 December 2023 Avacta Group plc (“Avacta” or “the Group” or “the Company”) Appointment of Chief Business Officer Appointment signals commercial emphasis for Avacta to leverage clinical progress Avacta Group plc (AIM: AVCT...
This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Se...